Austrianova Overview

  • Founded
  • 2001
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $47.2M
Latest Deal Amount
  • Investors
  • 3

Austrianova General Information

Description

Developer of a cell encapsulation technology created to protect, isolate, store and transport human and animal cells. The company utilizes a proprietary living-cell encapsulation technology for mammalian and bacterial cells which is designed to protect the encapsulated cells from rejection by the immune system by allowing the cells to be transported, stored and implanted at specific sites in patients, thus allowing doctors and healthcare organizations to deliver strong cells and medicine in patients with weak immune systems.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Drug Discovery
Primary Office
  • The Gemini, Suite 03-15
  • Singapore Science Park 2, 41 Science Park Road
  • Singapore, 117610
  • Singapore
+65 6779 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Austrianova Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series B) 05-Jun-2007 $47.2M 000.00 Completed Clinical Trials - General
1. Early Stage VC 000.00 000.00 Completed Clinical Trials - General
To view Austrianova’s complete valuation and funding history, request access »

Austrianova Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a cell encapsulation technology created to protect, isolate, store and transport human and animal cells. Th
Drug Delivery
Singapore, Singapore
000.00
00000000000 000.00

0000 000

re eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui offic
0000000000000
Cambridgeshire, United Kingdom
00 As of 0000
00.000
0000000 0000 00.000

00000000

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatu
0000000000000
Chicago, IL
00 As of 0000
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Austrianova Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Axol Biosciences Private Equity-Backed Cambridgeshire, United Kingdom 00 00.000 0000000 0000 00.000
000000000 Formerly VC-backed Chicago, IL 00 000000&0
0000000 Venture Capital-Backed Farmington, CT 0 00.000 0000000000 00.000
000000000000 00000 Venture Capital-Backed Madison, WI 00.000 0000000000 0 00.000
0000000000 0000000 Formerly PE-Backed Beit-Haemek, Israel 000 0000 000000&0 0000
You’re viewing 5 of 11 competitors. Get the full list »

Austrianova Executive Team (6)

Name Title Board Seat Contact Info
Walter Gunzburg Co-Founder, Chief Technology Officer & Chairman
Rahul Pawa Chief Production Officer
Brian Salmons Ph.D Co-Founder, Chief Executive Officer & President
Louise Bussieres Chief Financial Officer
John Dangerfield Ph.D Chief Operating Officer
You’re viewing 5 of 6 executive team members. Get the full list »

Austrianova Board Members (1)

Name Representing Role Since
Walter Gunzburg Austrianova Co-Founder, Chief Technology Officer & Chairman 000 0000
To view Austrianova’s complete board members history, request access »

Austrianova Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
AT Treuhand Corporation Minority 000 0000 000000 0
Omni Technology Invest Venture Capital Minority 000 0000 000000 0
Ryan Group Holdings Holding Company Minority 000 0000 000000 0
To view Austrianova’s complete investors history, request access »